Dyne Therapeutics Inc (DYN)
29.69
-0.04
(-0.13%)
USD |
NASDAQ |
Nov 22, 16:00
29.74
+0.05
(+0.17%)
After-Hours: 20:00
Dyne Therapeutics Price to Book Value: 4.282 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 4.282 |
| November 21, 2024 | 4.288 |
| November 20, 2024 | 4.326 |
| November 19, 2024 | 4.281 |
| November 18, 2024 | 4.232 |
| November 15, 2024 | 4.095 |
| November 14, 2024 | 4.372 |
| November 13, 2024 | 4.923 |
| November 12, 2024 | 4.230 |
| November 11, 2024 | 4.057 |
| November 08, 2024 | 4.108 |
| November 07, 2024 | 4.221 |
| November 06, 2024 | 4.299 |
| November 05, 2024 | 4.128 |
| November 04, 2024 | 4.151 |
| November 01, 2024 | 4.145 |
| October 31, 2024 | 4.162 |
| October 30, 2024 | 4.211 |
| October 29, 2024 | 4.358 |
| October 28, 2024 | 4.439 |
| October 25, 2024 | 4.432 |
| October 24, 2024 | 4.485 |
| October 23, 2024 | 4.667 |
| October 22, 2024 | 4.816 |
| October 21, 2024 | 4.828 |
| Date | Value |
|---|---|
| October 18, 2024 | 5.082 |
| October 17, 2024 | 5.009 |
| October 16, 2024 | 5.105 |
| October 15, 2024 | 4.844 |
| October 14, 2024 | 4.804 |
| October 11, 2024 | 4.856 |
| October 10, 2024 | 4.696 |
| October 09, 2024 | 4.618 |
| October 08, 2024 | 4.778 |
| October 07, 2024 | 4.569 |
| October 04, 2024 | 4.699 |
| October 03, 2024 | 4.839 |
| October 02, 2024 | 5.127 |
| October 01, 2024 | 5.013 |
| September 30, 2024 | 5.180 |
| September 27, 2024 | 4.382 |
| September 26, 2024 | 4.484 |
| September 25, 2024 | 4.518 |
| September 24, 2024 | 4.326 |
| September 23, 2024 | 4.485 |
| September 20, 2024 | 4.739 |
| September 19, 2024 | 4.716 |
| September 18, 2024 | 4.448 |
| September 17, 2024 | 4.481 |
| September 16, 2024 | 4.455 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6694
Minimum
Jun 02 2022
26.80
Maximum
Mar 28 2024
3.852
Average
2.593
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 8.936 |
| Capricor Therapeutics Inc | 12.40 |
| Regenxbio Inc | 1.576 |
| Catalyst Pharmaceuticals Inc | 3.876 |
| Novavax Inc | -- |
Price to Book Value Related Metrics
| Price | 29.69 |
| Earnings Yield | -11.99% |
| Market Cap | 3.021B |